Gayland O. Hethcoat II’s Insights

73 total results. Page 1 of 7.

Health Care Counsel Blog
CMS ACCESS Model Update: Payment Rates and Performance Targets Released for 2026–2027
Longevity Lens
ARPA-H Emerges as Top Longevity Agency Amid Funding and Staffing Fluctuations
Longevity Lens
The Regulatory Roadmap: Five Critical Questions for Evaluating Regulatory Risk for Longevity Companies
Longevity Lens
The Eyes Have It: FDA Approves Phase 1 Clinical Trial of Life Biosciences’ Reprogramming Therapy for Vision Loss
Longevity Lens
Lupo and Hethcoat Quoted on ArentFox Schiff Launch of Longevity & Healthspan Industry Group
Longevity Lens
ArentFox Schiff Launches First-of-Its-Kind Longevity & Healthspan Industry Group
Health Care Counsel Blog
Top Legal Challenges for the Health Care Industry in 2026
Longevity Lens
Staying on TEMPO: Five Things for Digital Health Companies to Know About the FDA’s New Pilot
Longevity Lens
Whoop There It Is: FDA Warning Letter Now Anchors a Class Action Against Whoop
Press Release
AFS Advises Clearwater Security and Compliance in Sale Transaction
Health Care Counsel Blog
HHS Signals Heightened Information Blocking Enforcement
News
Hethcoat Quoted on OCR Enforcement of HIPAA Security Risk Analysis Requirement